Terminal incentive salience index, average of daily incentive salience index for days 4 and 5
Tags: Behavior · Motivation
Project: p50_shelly_flagel_2014
2 loci · 2 genes with independent associations · 2 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | 2 | 144900859 | 146298381 | 1 | 1 | 1.86e-07 | 4.08e-03 | 6.13e-02 | Rap2b |
2 | 5 | 137682119 | 138752373 | 1 | 1 | 5.46e-09 | 1.25e-01 | 1.62e-03 | Stk40 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.21 |
Adipose | alternative TSS | 0 | 0 | 1.17 |
Adipose | gene expression | 0 | 0 | 1.22 |
Adipose | isoform ratio | 0 | 0 | 1.2 |
Adipose | intron excision ratio | 0 | 0 | 1.18 |
Adipose | mRNA stability | 0 | 0 | 1.23 |
BLA | alternative polyA | 0 | 0 | 1.18 |
BLA | alternative TSS | 0 | 0 | 1.01 |
BLA | gene expression | 0 | 0 | 1.24 |
BLA | isoform ratio | 0 | 0 | 1.14 |
BLA | intron excision ratio | 0 | 0 | 1.19 |
BLA | mRNA stability | 0 | 0 | 1.26 |
Brain | alternative polyA | 0 | 0 | 1.17 |
Brain | alternative TSS | 0 | 0 | 1.03 |
Brain | gene expression | 0 | 0 | 1.23 |
Brain | isoform ratio | 0 | 0 | 1.19 |
Brain | intron excision ratio | 0 | 0 | 1.22 |
Brain | mRNA stability | 0 | 0 | 1.23 |
Eye | alternative polyA | 0 | 0 | 1.09 |
Eye | alternative TSS | 0 | 0 | 1.22 |
Eye | gene expression | 0 | 0 | 1.14 |
Eye | isoform ratio | 0 | 0 | 1.23 |
Eye | intron excision ratio | 0 | 0 | 1.17 |
Eye | mRNA stability | 0 | 0 | 1.54 |
IL | alternative polyA | 0 | 0 | 1.12 |
IL | alternative TSS | 0 | 0 | 1.01 |
IL | gene expression | 0 | 0 | 1.17 |
IL | isoform ratio | 0 | 0 | 1.12 |
IL | intron excision ratio | 0 | 0 | 1.36 |
IL | mRNA stability | 0 | 0 | 1.39 |
LHb | alternative polyA | 0 | 0 | 1.12 |
LHb | alternative TSS | 0 | 0 | 1.1 |
LHb | gene expression | 0 | 0 | 1.24 |
LHb | isoform ratio | 0 | 0 | 1.19 |
LHb | intron excision ratio | 0 | 0 | 1.25 |
LHb | mRNA stability | 0 | 0 | 1.37 |
Liver | alternative polyA | 0 | 0 | 1.3 |
Liver | alternative TSS | 0 | 0 | 1.17 |
Liver | gene expression | 1 | 0 | 1.17 |
Liver | isoform ratio | 0 | 0 | 1.19 |
Liver | intron excision ratio | 0 | 0 | 1.17 |
Liver | mRNA stability | 1 | 0 | 1.2 |
NAcc | alternative polyA | 0 | 0 | 1.17 |
NAcc | alternative TSS | 0 | 0 | 1.03 |
NAcc | gene expression | 0 | 0 | 1.23 |
NAcc | isoform ratio | 0 | 0 | 1.18 |
NAcc | intron excision ratio | 0 | 0 | 1.23 |
NAcc | mRNA stability | 0 | 0 | 1.28 |
OFC | alternative polyA | 0 | 0 | 1.09 |
OFC | alternative TSS | 0 | 0 | 0.99 |
OFC | gene expression | 0 | 0 | 1.19 |
OFC | isoform ratio | 0 | 0 | 1.28 |
OFC | intron excision ratio | 0 | 0 | 1.33 |
OFC | mRNA stability | 0 | 0 | 1.27 |
PL | alternative polyA | 0 | 0 | 1.21 |
PL | alternative TSS | 0 | 0 | 1.04 |
PL | gene expression | 0 | 0 | 1.22 |
PL | isoform ratio | 0 | 0 | 1.18 |
PL | intron excision ratio | 0 | 0 | 1.23 |
PL | mRNA stability | 0 | 0 | 1.23 |